MICRAININ

Post-LOE

aspirin; meprobamate

Bausch Health

ANDAORALTABLET

Approved

Jul 1978

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

MICRAININ (aspirin; meprobamate) by Bausch Health is clinical pharmacology meprobamate is a carbamate derivative which has been shown (in animal and/or human studies) to have effects at multiple sites in the central nervous system, including the thalamus and limbic system. Approved for anxiety. First approved in 1978.

Drug data last refreshed 3d ago

Mechanism of Action

CLINICAL PHARMACOLOGY Meprobamate is a carbamate derivative which has been shown (in animal and/or human studies) to have effects at multiple sites in the central nervous system, including the thalamus and limbic system. Aspirin is a nonnarcotic analgesic with antipyretic and anti-inflammatory…

Indications (1)

anxiety

Company

Worked on MICRAININ at Bausch Health? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.